Lotensin Eye Drops

About Lotensin .05 mg + 5 mg/ml Eye Drops

Lotensin eye drops are made by Advanced Chemical Industries PLC and contain latanoprost and timolol. The strength is .05 mg + 5 mg/ml. This combination is used for certain eye pressure conditions.

What is Lotensin .05 mg + 5 mg/ml Eye Drops?

Lotensin is an eye drop medicine from Advanced Chemical Industries PLC. It combines latanoprost and timolol. Latanoprost is a prostaglandin-like substance that helps fluid drain from the eye, and timolol is a beta-blocker that reduces fluid production inside the eye. Together they are intended for people with open-angle glaucoma or raised pressure inside the eye who have not responded well enough to other pressure-lowering medicines. It is a prescription medicine, and your eye doctor will decide whether it is suitable for you.

Uses of Lotensin

Lotensin is indicated for lowering pressure inside the eye in adults with open-angle glaucoma or ocular hypertension. It is used when other pressure-lowering treatments, such as beta-blockers, prostaglandins or other agents, have not worked well enough. It is not recommended for children because its safety and effectiveness in children have not been established. Your eye doctor will confirm whether this medicine is appropriate for your eye condition.

How to use Lotensin

Use Lotensin only as your eye doctor instructs. The doctor decides the dose and course of treatment for you. The drops are placed in the affected eye or eyes. If you miss a dose, continue with the next dose as normal, but ask your doctor or pharmacist if you are unsure. Do not change how often you use it on your own. Keep the bottle clean and avoid letting the tip touch your eye or any surface.

Side effects of Lotensin

Lotensin is generally well tolerated. Commonly reported effects include eye irritation such as stinging, burning and itching, redness of the eye, corneal problems, conjunctivitis, eyelid inflammation, eye pain, headache and skin rash. Darkening, thickening and lengthening of eyelashes have been reported, and increased iris pigmentation can occur, especially in people with certain eye colours. Tell your doctor if you notice any side effect or if it bothers you.

Safety and precautions

Before using Lotensin, tell your doctor if you have asthma or other reactive airway disease, severe chronic obstructive pulmonary disease, certain heart rhythm problems, heart failure or shock, or if you are allergic to any ingredient. Use with caution if you have macular edema, have had cataract surgery with a torn lens capsule, have diabetes or low blood sugar, wear contact lenses, or drive or use machines. During pregnancy, it should be used only if the benefit justifies the potential risk to the fetus. It should be used with caution in breastfeeding women. Ask your doctor first in all these situations.

Frequently asked questions

Is Lotensin safe during pregnancy or breastfeeding?

No reproduction studies have been done with this combination. It should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Latanoprost and timolol may pass into breast milk, so it should be used with caution in nursing women. Ask your doctor before using it.

What is Lotensin used for and what kind of medicine is it?

Lotensin is an eye drop medicine combining latanoprost and timolol. It is used to lower pressure inside the eye in adults with open-angle glaucoma or ocular hypertension when other pressure-lowering treatments have not worked well enough. Your eye doctor will decide if it is suitable for you.

How should Lotensin be stored?

Store Lotensin in a refrigerator. Once the bottle has been opened, it may be kept below a cool room temperature. Ask your pharmacist for the exact storage conditions for your bottle, and keep it out of reach of children.

Can children use Lotensin?

Safety and effectiveness in children have not been established, so Lotensin is not recommended for use in children. Ask your eye doctor about suitable options for a child.

Also available as

.25 % (Eye Drops)

Indications

This preparation is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufftciently responsive to β-blockers, prostaglandins or other IOP lowering agents.

Pharmacology

Latanoprost is an analogue of prostaglandin F2α, it reduces intraocular pressure (IOP) by increasing outflow of aqueous humour.

Timolol is a non-selective adrenergic blocker. It lowers IOP by decreasing the formation of aqueous by the ciliary epithelium.

Dosage & Administration

Adult or elderly: The recommended adult (including the elderly) dosage of is one drop in the affected eye(s) once daily. If one dose is missed, treatment should continue with the next dose as normal.

Children: Safety and effectiveness in children has not been established. This is therefore is not recommended for use in children.

Interaction

No specific interaction studies have been performed with this preparation. Patients who are receiving treatment with this preparation and an oral β-adrenergic blocking agent should be observed for potential additive effects of β-blockade, both systemic and on lntraocular pressure The concomitant use of two topical β-adrenergic blocking agents is not recommended. Although this preparation alone has little or no effect on pupil size, mydriasis has occasionally been reported when Timolol is given with epinephrine. β-blockers may increase the hypoglycemic effect of antidiabetic agents. In vitro studies have shown that precipitation occurs when eye drops containing thimerosal are mixed with Benzalkonium chloride, the preservative used in this preparatlon. If such drugs are used they should be administered with an interval of at least 5 minutes between applications. Similarly, several contact lens soakinq solutions contain thimerosal.

Contraindications

This combination is contraindicated in patients with Known hypersensitivity to Latanoprost, Timolol and benzalkonium chloride or any other ingredient in the product. This combination is also contraindicated for the following conditions such as reactive airway disease including bronchial asthma, history of bronchial asthma or severe chronic obstructive pulmonary disease, sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, or cardiogenic shock.

Side Effects

This combination is generally well tolerated. The most frequent findings of increased iris pigmentation were in patients with green-brown, yellow-brown and blue/grey/brown irides. In patients with homogeneously blue, grey, green or brown eyes, the change was only rarely seen. Darkening, thickening and lengthening of the eye lashes have been reported. The most frequently reported undesirable effects in clinical trials were irritation of the eye, including stinging, burning and ,itching, eye hyperaemia, corneal disorders, coniunctivitis blepharitis, eye pain, headache and skin rash.

Pregnancy & Lactation

No reproduction toxicity studies have been conducted with this combination.This combination should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Latanoprost and its metabolites may pass into breast milk. Timolol maleate has been detected in human milk following ocular administration. Because of the potential serious adverse reactions in nursing infants, this preparation should be used with caution in nursing women.

Precautions & Warnings

This preparation should be used with caution in patients with macular edema, aphakic patients, pseudophakic parients with a torn posterior lens capsule or in patients with known risk factors for macular edema.It should be administered with caution in patients subjected to spontaneous hypoglycaemia or to diabetic patients who are receiving insulin or oral hypoglycaemic agents.Caution should also be exercised to patients wearing contact lenses or drive and use machines.

Overdose Effects

There is no human data available on over dosage with this preparation.Symptoms of systemic Timolol over dosage are bradycardia, hypotenslon, bronchospasm, and cardiac arrest. If such symptoms occur,treatment should be symptomatic and supportive. The ocular effects of Latanoprost administered at high doses are not known. If overdose with this preparation occurs, treatment should be symptomatic.

Storage Conditions

Store at 2-8° C. For opened bottles, may store below 25° C.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.